Literature DB >> 8828488

Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat.

T B Usdin1, T I Bonner, G Harta, E Mezey.   

Abstract

The PTH2 receptor is a recently identified G protein-coupled receptor activated by PTH. Its amino acid sequence is most similar to the PTH/PTHrP receptor, but unlike the PTH/PTHrP receptor, it is activated by PTH and not by PTH-related peptide. We previously demonstrated using Northern blots that expression of PTH2 receptor messenger RNA was greatest within the brain and occurred at lower levels in pancreas, testis, and placenta. We have now obtained a complementary DNA encoding the rat PTH2 receptor and used it to study the distribution of the PTH2 receptor using in situ hybridization histochemistry. PTH2 receptor messenger RNA is abundantly expressed in arterial and cardiac endothelium and at lower levels in vascular smooth muscle. It is also abundant in the lung, both within bronchi and in the parenchyma, and is present within the exocrine pancreas. It is expressed by sperm in the head of the epididymis. A small number of cells associated with the vascular pole of renal glomeruli express the receptor. These data suggest that the PTH2 receptor may be responsible for PTH effects in a number of physiological systems.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8828488     DOI: 10.1210/endo.137.10.8828488

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  24 in total

Review 1.  PTH and PTHrP effects on the skeleton.

Authors:  A C Karaplis; D Goltzman
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception.

Authors:  Arpad Dobolyi; Hiroshi Ueda; Hitoshi Uchida; Miklós Palkovits; Ted B Usdin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

Review 3.  Hormonal regulation and implication of cell signaling in calcium transfer by placenta.

Authors:  J Lafond; I Goyer-O'Reilly; M Laramée; L Simoneau
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

4.  Development of a rat parathyroid hormone 2 receptor antagonist.

Authors:  Jonathan Kuo; Ted B Usdin
Journal:  Peptides       Date:  2007-01-04       Impact factor: 3.750

Review 5.  The role of vitamin D in male fertility: A focus on the testis.

Authors:  Cristina de Angelis; Mariano Galdiero; Claudia Pivonello; Francesco Garifalos; Davide Menafra; Federica Cariati; Ciro Salzano; Giacomo Galdiero; Mariangela Piscopo; Alfonso Vece; Annamaria Colao; Rosario Pivonello
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

6.  Predicting hospital cost in CKD patients through blood chemistry values.

Authors:  Russell W Bessette; Randy L Carter
Journal:  BMC Nephrol       Date:  2011-12-01       Impact factor: 2.388

7.  Parathyroid hormone stimulates juxtaglomerular cell cAMP accumulation without stimulating renin release.

Authors:  Douglas K Atchison; Pamela Harding; M Cecilia Ortiz-Capisano; Edward L Peterson; William H Beierwaltes
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-15

8.  TIP39/parathyroid hormone type 2 receptor signaling is a potent inhibitor of chondrocyte proliferation and differentiation.

Authors:  Dibiyendu Panda; David Goltzman; Harald Jüppner; Andrew C Karaplis
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-25       Impact factor: 4.310

9.  Increased fear- and stress-related anxiety-like behavior in mice lacking tuberoinfundibular peptide of 39 residues.

Authors:  D B Fegley; A Holmes; T Riordan; C A Faber; J R Weiss; S Ma; S Batkai; P Pacher; A Dobolyi; A Murphy; M W Sleeman; T B Usdin
Journal:  Genes Brain Behav       Date:  2008-09-17       Impact factor: 3.449

10.  Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis.

Authors:  Jared P Reis; Denise von Mühlen; Erin D Michos; Edgar R Miller; Lawrence J Appel; Maria R Araneta; Elizabeth Barrett-Connor
Journal:  Atherosclerosis       Date:  2009-06-06       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.